Compare FINV & ENOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | FINV | ENOV |
|---|---|---|
| Founded | 2007 | 1995 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Fluid Controls |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.4B |
| IPO Year | 2017 | 2008 |
| Metric | FINV | ENOV |
|---|---|---|
| Price | $5.64 | $22.77 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 8 |
| Target Price | $11.55 | ★ $48.75 |
| AVG Volume (30 Days) | ★ 1.1M | 1.0M |
| Earning Date | 03-16-2026 | 05-07-2026 |
| Dividend Yield | ★ 5.00% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $6.02 | $6.49 |
| Revenue Next Year | N/A | $5.56 |
| P/E Ratio | $3.87 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $4.70 | $21.00 |
| 52 Week High | $10.90 | $40.70 |
| Indicator | FINV | ENOV |
|---|---|---|
| Relative Strength Index (RSI) | 52.08 | 42.95 |
| Support Level | $5.44 | $21.30 |
| Resistance Level | $5.96 | $23.57 |
| Average True Range (ATR) | 0.25 | 1.21 |
| MACD | 0.04 | -0.19 |
| Stochastic Oscillator | 34.96 | 11.79 |
FinVolution Group is a provider of online consumer finance in China. The company offers various loan products, making financial services available to borrowers anytime, anywhere; designs a loan transaction process, and offers tailored risk-based pricing. It offers short-term loans to borrowers to meet immediate credit needs while allowing them to gradually establish their credit history through activities on the company's platform. The company generates revenues from fees charged to borrowers. The Group's long-lived assets are located in the PRC, and its revenues are derived from within the PRC.
Enovis Corp is a medical technology manufacturer and distributor of medical devices used in reconstructive surgery, rehabilitation, pain management, and physical therapy. Its products support patient care from injury prevention through post-surgical or post-injury rehabilitation and treatment of degenerative conditions. The company's reportable segments include Prevention & Recovery and Reconstructive segments. The majority of revenueis derived from the Prevention & Recovery segment, which includes products that are used by orthopedic specialists, primary care physicians, physical therapists, chiropractors, athletic trainers and other healthcare professionals to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformitiesand sports-related injuries.